Cargando…

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey

In older patients with Parkinson’s disease (PD), the use of dopamine agonists (DA) has been limited due to uncertainties related to their tolerability in spite of potential gains with the advent of longer acting or transdermal therapies. Comparative real-life data addressing the tolerability of DA t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizos, A., Sauerbier, A., Falup-Pecurariu, C., Odin, P., Antonini, A., Martinez-Martin, P., Kessel, B., Henriksen, T., Silverdale, M., Durner, G., Ray Chaudhuri, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2020
Materias:	Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248021/ https://www.ncbi.nlm.nih.gov/pubmed/32372166 http://dx.doi.org/10.1007/s00702-020-02168-0

Ejemplares similares

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
por: Tall, P., et al.
Publicado: (2023)

Editorial: Movement Disorders and Sleep – Underlying Mechanisms, Clinical Aspects and Treatment
por: Falup-Pecurariu, Cristian, et al.
Publicado: (2019)

Dry eye in Parkinson's disease: a narrative review
por: Ungureanu, Larisa, et al.
Publicado: (2023)

Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

Chaudhuri’s Dashboard of Vitals in Parkinson’s syndrome: an unmet need underpinned by real life clinical tests
por: Qamar, Mubasher A., et al.
Publicado: (2023)

Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Jing, Xiao-Zhong, et al.
Publicado: (2023)

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
por: Jenner, P., et al.
Publicado: (2023)

Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis
por: Chen, Xiang-Ting, et al.
Publicado: (2023)

Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers—Study Protocol for a Multicentre, Randomized Controlled Trial
por: Meinders, Marjan J., et al.
Publicado: (2021)

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
por: Chaudhuri, K. Ray, et al.
Publicado: (2013)

E-learning preferences of European junior neurologists—an EAYNT survey
por: Sztriha, Laszlo K., et al.
Publicado: (2012)

Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
por: Lau, Yue Hui, et al.
Publicado: (2022)

Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia
por: Klingelhoefer, Lisa, et al.
Publicado: (2020)

Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
por: LeWitt, Peter A., et al.
Publicado: (2012)

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023)

Reward and value coding by dopamine neurons in non-human primates
por: Alikaya, Aydin, et al.
Publicado: (2017)

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study
por: Vijiaratnam, Nirosen, et al.
Publicado: (2021)

Motivational learning biases are differentially modulated by genetic determinants of striatal and prefrontal dopamine function
por: Richter, Anni, et al.
Publicado: (2021)

Hearing loss, depression, and cognition in younger and older adult CI candidates
por: Huber, Maria, et al.
Publicado: (2023)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

Computerized Cognitive Training by Healthy Older and Younger Adults: Age Comparisons of Overall Efficacy and Selective Effects on Cognition
por: Ng, Nicole F., et al.
Publicado: (2021)

Triglyceride-glucose index predicts death in patients with stroke younger than 65
por: Liu, Ruishan, et al.
Publicado: (2023)

Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases
por: Le Nogue, Déborah, et al.
Publicado: (2019)

Multicentric Spinal Pilocytic Astrocytoma Presenting with Syringomyelia
por: Alanazi, Ahad A, et al.
Publicado: (2021)

Does the Degree of Trunk Bending Predict Patient Disability, Motor Impairment, Falls, and Back Pain in Parkinson's Disease?
por: Geroin, Christian, et al.
Publicado: (2020)

Participation in Younger and Older Adults Post-stroke: Frequency, Importance, and Desirability of Engagement in Activities
por: Toglia, Joan, et al.
Publicado: (2019)

Efficacy and Safety of Rotigotine Transdermal Patch on Neuropsychiatric Symptoms of Parkinson's Disease: An Updated Meta-Analysis and Systematic Review
por: Yan, Junqiang, et al.
Publicado: (2021)

Current and novel infusion therapies for patients with Parkinson's disease
por: Antonini, Angelo, et al.
Publicado: (2023)

The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions
por: Adler, G, et al.
Publicado: (2014)

Benefits and safety of transdermal glyceryl trinitrate in acute stroke: a systematic review and meta-analysis of randomised trials (protocol)
por: Lim, Beng Leong, et al.
Publicado: (2021)

Cranial Nerve Enhancement in Multiple Sclerosis Is Associated With Younger Age at Onset and More Severe Disease
por: Haider, Lukas, et al.
Publicado: (2019)

Sex Differences in Ischemic Stroke Within the Younger Age Group: A Register-Based Study
por: Norman, Kristina, et al.
Publicado: (2022)

The Pressor Response to the Drinking of Cold Water and Cold Carbonated Water in Healthy Younger and Older Adults
por: Kubota, Satoshi, et al.
Publicado: (2022)

SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease
por: Robertson, Brian D., et al.
Publicado: (2018)

Structural connectivity and brain network analyses in Parkinson's disease: A cross-sectional and longitudinal study
por: Bergamino, Maurizio, et al.
Publicado: (2023)

Increased Intraepidermal Nerve Fiber Degeneration and Impaired Regeneration Relate to Symptoms and Deficits in Parkinson's Disease
por: Jeziorska, Maria, et al.
Publicado: (2019)

Transient Global Amnesia (TGA): Younger Age and Absence of Cerebral Microangiopathy Are Potentially Predisposing Factors for TGA Recurrence
por: Rogalewski, Andreas, et al.
Publicado: (2021)

Effect of bispectral index-guided total intravenous anesthesia in younger children: A prospective, randomized, controlled trial
por: Liu, Guoliang, et al.
Publicado: (2022)

Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
por: O'Gorman Tuura, Ruth L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q7so2plqurqba8d2du8ft7k3f2